smartway pharma limited Company Information
Company Number
08252650
Next Accounts
Dec 2025
Directors
-
Shareholders
smartway pw holdings ltd
kaushik patel
Group Structure
View All
Industry
Wholesale of perfume and cosmetics
Registered Address
the old mill 9 soar lane, leicester, leicestershire, LE3 5DE
Website
www.smartwaypharma.co.uksmartway pharma limited Estimated Valuation
Pomanda estimates the enterprise value of SMARTWAY PHARMA LIMITED at £1.3m based on a Turnover of £2.2m and 0.59x industry multiple (adjusted for size and gross margin).
smartway pharma limited Estimated Valuation
Pomanda estimates the enterprise value of SMARTWAY PHARMA LIMITED at £2m based on an EBITDA of £482.5k and a 4.11x industry multiple (adjusted for size and gross margin).
smartway pharma limited Estimated Valuation
Pomanda estimates the enterprise value of SMARTWAY PHARMA LIMITED at £1.4m based on Net Assets of £535.2k and 2.68x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Smartway Pharma Limited Overview
Smartway Pharma Limited is a live company located in leicestershire, LE3 5DE with a Companies House number of 08252650. It operates in the wholesale of perfume and cosmetics sector, SIC Code 46450. Founded in October 2012, it's largest shareholder is smartway pw holdings ltd with a 90% stake. Smartway Pharma Limited is a established, small sized company, Pomanda has estimated its turnover at £2.2m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Smartway Pharma Limited Health Check
Pomanda's financial health check has awarded Smartway Pharma Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 5 areas for improvement. Company Health Check FAQs


2 Strong

5 Regular

5 Weak

Size
annual sales of £2.2m, make it smaller than the average company (£16.5m)
- Smartway Pharma Limited
£16.5m - Industry AVG

Growth
3 year (CAGR) sales growth of -14%, show it is growing at a slower rate (10.2%)
- Smartway Pharma Limited
10.2% - Industry AVG

Production
with a gross margin of 42.1%, this company has a comparable cost of product (42.1%)
- Smartway Pharma Limited
42.1% - Industry AVG

Profitability
an operating margin of 21.9% make it more profitable than the average company (5.5%)
- Smartway Pharma Limited
5.5% - Industry AVG

Employees
with 7 employees, this is below the industry average (46)
- Smartway Pharma Limited
46 - Industry AVG

Pay Structure
on an average salary of £45.1k, the company has an equivalent pay structure (£45.1k)
- Smartway Pharma Limited
£45.1k - Industry AVG

Efficiency
resulting in sales per employee of £314.7k, this is equally as efficient (£338k)
- Smartway Pharma Limited
£338k - Industry AVG

Debtor Days
it gets paid by customers after 69 days, this is later than average (49 days)
- Smartway Pharma Limited
49 days - Industry AVG

Creditor Days
its suppliers are paid after 88 days, this is slower than average (38 days)
- Smartway Pharma Limited
38 days - Industry AVG

Stock Days
it holds stock equivalent to 132 days, this is in line with average (118 days)
- Smartway Pharma Limited
118 days - Industry AVG

Cash Balance
has cash to cover current liabilities for 4 weeks, this is less cash available to meet short term requirements (15 weeks)
4 weeks - Smartway Pharma Limited
15 weeks - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 49.5%, this is a similar level of debt than the average (53.2%)
49.5% - Smartway Pharma Limited
53.2% - Industry AVG
SMARTWAY PHARMA LIMITED financials

Smartway Pharma Limited's latest turnover from March 2024 is estimated at £2.2 million and the company has net assets of £535.2 thousand. According to their latest financial statements, we estimate that Smartway Pharma Limited has 7 employees and maintains cash reserves of £47.8 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Feb 2018 | Feb 2017 | Feb 2016 | Feb 2015 | Feb 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||
Other Income Or Grants | |||||||||||
Cost Of Sales | |||||||||||
Gross Profit | |||||||||||
Admin Expenses | |||||||||||
Operating Profit | |||||||||||
Interest Payable | |||||||||||
Interest Receivable | |||||||||||
Pre-Tax Profit | |||||||||||
Tax | |||||||||||
Profit After Tax | |||||||||||
Dividends Paid | |||||||||||
Retained Profit | |||||||||||
Employee Costs | |||||||||||
Number Of Employees | |||||||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Feb 2018 | Feb 2017 | Feb 2016 | Feb 2015 | Feb 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock & work in progress | 462,792 | 372,653 | 141,884 | 147,179 | 110,774 | 104,607 | 52,424 | 0 | 0 | 0 | 0 |
Trade Debtors | 421,115 | 573,651 | 494,792 | 677,250 | 378,750 | 158,311 | 26,195 | 0 | 30 | 0 | 1,000 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 127,267 | 105,643 | 17,086 | 0 | 1,688 | 13,989 | 0 | 0 | 0 | 0 | 0 |
Cash | 47,778 | 174,271 | 311,369 | 62,980 | 40,562 | 27,022 | 45,793 | 426 | 372 | 12 | 315 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 1,058,952 | 1,226,218 | 965,131 | 887,409 | 531,774 | 303,929 | 124,412 | 426 | 402 | 12 | 1,315 |
total assets | 1,058,952 | 1,226,218 | 965,131 | 887,409 | 531,774 | 303,929 | 124,412 | 426 | 402 | 12 | 1,315 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 309,923 | 1,027,958 | 773,975 | 813,032 | 333,641 | 130,894 | 6,029 | 0 | 0 | 34,009 | 35,009 |
Group/Directors Accounts | 0 | 0 | 92,322 | 92,322 | 93,822 | 93,822 | 93,822 | 35,456 | 34,996 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 213,848 | 29,306 | 29,237 | 11,013 | 17,246 | 14,025 | 8,507 | 0 | 0 | 0 | 0 |
total current liabilities | 523,771 | 1,057,264 | 895,534 | 916,367 | 444,709 | 238,741 | 108,358 | 35,456 | 34,996 | 34,009 | 35,009 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total liabilities | 523,771 | 1,057,264 | 895,534 | 916,367 | 444,709 | 238,741 | 108,358 | 35,456 | 34,996 | 34,009 | 35,009 |
net assets | 535,181 | 168,954 | 69,597 | -28,958 | 87,065 | 65,188 | 16,054 | -35,030 | -34,594 | -33,997 | -33,694 |
total shareholders funds | 535,181 | 168,954 | 69,597 | -28,958 | 87,065 | 65,188 | 16,054 | -35,030 | -34,594 | -33,997 | -33,694 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Feb 2018 | Feb 2017 | Feb 2016 | Feb 2015 | Feb 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||
Operating Profit | |||||||||||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax | |||||||||||
Stock | 90,139 | 230,769 | -5,295 | 36,405 | 6,167 | 52,183 | 52,424 | 0 | 0 | 0 | 0 |
Debtors | -130,912 | 167,416 | -165,372 | 296,812 | 208,138 | 146,105 | 26,195 | -30 | 30 | -1,000 | 1,000 |
Creditors | -718,035 | 253,983 | -39,057 | 479,391 | 202,747 | 124,865 | 6,029 | 0 | -34,009 | -1,000 | 35,009 |
Accruals and Deferred Income | 184,542 | 69 | 18,224 | -6,233 | 3,221 | 5,518 | 8,507 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | |||||||||||
Investing Activities | |||||||||||
capital expenditure | |||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | |||||||||||
Financing Activities | |||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | -92,322 | 0 | -1,500 | 0 | 0 | 58,366 | 460 | 34,996 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | |||||||||||
interest | |||||||||||
cash flow from financing | |||||||||||
cash and cash equivalents | |||||||||||
cash | -126,493 | -137,098 | 248,389 | 22,418 | 13,540 | -18,771 | 45,367 | 54 | 360 | -303 | 315 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | -126,493 | -137,098 | 248,389 | 22,418 | 13,540 | -18,771 | 45,367 | 54 | 360 | -303 | 315 |
smartway pharma limited Credit Report and Business Information
Smartway Pharma Limited Competitor Analysis

Perform a competitor analysis for smartway pharma limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in LE3 area or any other competitors across 12 key performance metrics.
smartway pharma limited Ownership
SMARTWAY PHARMA LIMITED group structure
Smartway Pharma Limited has no subsidiary companies.
Ultimate parent company
1 parent
SMARTWAY PHARMA LIMITED
08252650
smartway pharma limited directors
Smartway Pharma Limited currently has 1 director, undefined undefined serving since - .
officer | country | age | start | end | role |
---|
P&L
March 2024turnover
2.2m
-39%
operating profit
482.5k
0%
gross margin
42.1%
-3.21%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
535.2k
+2.17%
total assets
1.1m
-0.14%
cash
47.8k
-0.73%
net assets
Total assets minus all liabilities
smartway pharma limited company details
company number
08252650
Type
Private limited with Share Capital
industry
46450 - Wholesale of perfume and cosmetics
incorporation date
October 2012
age
13
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
VERSANT ASSOCIATES LLP
address
the old mill 9 soar lane, leicester, leicestershire, LE3 5DE
Bank
-
Legal Advisor
-
smartway pharma limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to smartway pharma limited.
smartway pharma limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for SMARTWAY PHARMA LIMITED. This can take several minutes, an email will notify you when this has completed.
smartway pharma limited Companies House Filings - See Documents
date | description | view/download |
---|